1120515

Syntenza Pharmaceuticals, LLC — FEI 3015899066

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 12, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Edina, MN (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
1002221 CFR 310.305(a)Failure to develop written procedures